Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

24 results
Display

A Case of Multiple Bowen's Disease with Atypical Psoriasiform Large Plaque Associated with Internal Malignancies

Yoo HC, Lee SC, Kim SJ, Won YH

  • KMID: 1930644
  • Korean J Dermatol.
  • 1999 Oct;37(10):1487-1490.
We report a case of multiple Bowen's disease of probable arsenic origin associated with internal malignancies. A 63-year-old man who had a history of arsenicals injections showed pruritic erythematous 11...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Osteomyelitis on Maxilla Caused by Arsenic Trioxide

Choi BY, Yoo DH, Choi MK, Choi JG, Lee YJ, Jo BH

  • KMID: 1485195
  • J Korean Assoc Maxillofac Plast Reconstr Surg.
  • 2008 Nov;30(6):593-598.
Arsenic trioxide is one of the 'tooth pulp devitalizing agents' used through the dental history when anaesthesia was not available. But owing to its capacity to kill cells in surrounding...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Twenty Six Cases of Exfoliative Dermatitis: It's Clinical, Etiological, Laboratory Findings and Courses of Treatment, with Review of Literatures

Ihm CW, Kim YP

  • KMID: 1664387
  • Korean J Dermatol.
  • 1974 Jun;12(2):9-15.
Twenty six cases of Exfoliative dermatitis were found during the years from July of 1967 to June of 1972 at the department of dermatology of Chonnarn University Hospital, and the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Remission induction using arsenic trioxide in acute promyelocytic leukemia

Min CK

  • KMID: 2256189
  • Korean J Med.
  • 2008 Jun;74(6):593-595.
In acute promyelocytic leukemia (APL), all-trans retinoic acid (ATRA) triggers cell differentiation, while arsenic trioxide (ATO) generates partial differentiation and apoptosis. Standard initial treatment for patients with APL consists of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
In Vitro Magnetometric Evaluation for Toxicity to Alverolar Macrophage of Arsenic Compounds

Cho YC

  • KMID: 2283049
  • Korean J Prev Med.
  • 1999 Dec;32(4):467-472.
OBJECTIVES: This study was conducted to evaluate the cytotoxicity of gallium arsenide(GaAs), indium phosphide(InP) and indium arsenide(InAs) all of which are used as the semiconductor eletments in semiconductor industry. METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Acute Arsine (AsH3) Intoxication

Kim SM, Kim TY, Lee KS, Kim DH, Lee KE, Oh DJ, Yu SH

  • KMID: 2253630
  • Korean J Nephrol.
  • 2008 Jan;27(1):145-148.
The present report describes a case of arsine intoxication. A 36-year-old male technician who handled gas in a semiconductor laboratory was admitted with severe abdominal pain and dark-red-colored urine. He...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An Immunohistochemical Study of p53, mdm-2 and bcl-2 Protein Expression in Multiple Bowen's Disease with Invasive Carcinoma

Eun C, Ro YS, Kim YT, Lee CW, Yu HJ, Ihm CW, Choi KC, Suh MK

  • KMID: 2303310
  • Korean J Dermatol.
  • 1998 Aug;36(4):609-616.
BACKGROUND: Bowen's disease(BD) is an in situ squamous cell carcinoma(SCC) of the skin, which clinically presents as a scaly slightly elevated erythematous plaque. Approximately two thirds of patients with BD...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Salvage treatments with all-trans retinoic acid and arsenic trioxide-based regimens in acute promyelocytic leukemia

Cho YY, Kim JG, Chae YS, Moon JH, Ahn BM, Sohn SK

  • KMID: 2256190
  • Korean J Med.
  • 2008 Jun;74(6):596-604.
BACKGROUND/AIMS: Acute promyelocytic leukemia is a distinct subtype of acute myeloid leukemia with a specific clinical and molecular presentation. Treatment of acute promyelocytic leukemia with all-trans retinoic acid or arsenic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Central Nervous System Relapse in Patients with Acute Promyelocytic Leukemia Treated with All-trans Retinoic Acid

Kim EO, Gil SH, Choi JK, Lee HJ, Kim HJ, Lee JW, Min WS

  • KMID: 1966888
  • Korean J Med.
  • 2011 Feb;80(2):231-237.
Acute promyelocytic leukemia (APL) is distinguished from other subtypes of acute myeloid leukemia (AML) by its distinctive morphology, specific chromosomal abnormality, coagulopathy, and unique response to treatment with all-trans retinoic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Inhibition of cell growth and apoptosis in CaSki, cervical cancer cell line by arsenic compounds

Byun JM, Jeong DH, Lee DS, Kim JR, Kim YN, Jeong EJ, Sung MS, Lee KB, Kim KT

OBJECTIVE: To compare inhibition of cell growth and apoptosis in human cervical cancer cell lines (CaSki) by paclitaxel, cisplatin, arsenic trioxide and tetraarsenic oxide. METHODS: Inhibition of cell growth was determined...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vascular shutdown effects by tetraarsenic oxide in TC-1 cells implanted C57BL/6 mice

Namkung J, Bae SM, Lanying W, Oh EK, Shin JE, Kim YW, Kim TE, Park TC, Ahn WS

  • KMID: 2273689
  • Korean J Obstet Gynecol.
  • 2009 Feb;52(2):220-227.
OBJECTIVE: Arsenic trioxide (As2O3) is known to have potent anti-vascular activity and significantly suppress solid tumor growth. The present study was conducted to investigate the vascular shutdown effects of a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent advances in the diagnosis and management of childhood acute promyelocytic leukemia

Yoo ES

Since the successful introduction of all-trans-retinoic acid (ATRA) and its combination with anthracycline-containing chemotherapy, the prognosis for acute promyelocytic leukemia (APL) has markedly improved. With ATRA and anthracycline-based-chemotherapy, the complete...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Kidney Transplantation in a Patient with End Stage Renal Disease after Complete Remission of Acute Promyelocytic Leukemia

Chun HJ, Kim SJ, Sun IO, Chung BH, Kim JI, Moon IS, Min WS, Yang CW

In general, a 2-yr disease-free duration is recommended before kidney transplantation (KT) in end-stage renal disease (ESRD) patients who also have acute leukemia. However, the optimal disease-free interval has not...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Urinary Arsenic Concentrations and their Associated Factors in Korean Adults

Bae HS, Ryu DY, Choi BS, Park JD

  • KMID: 2317827
  • Toxicol Res.
  • 2013 Jun;29(2):137-142.
Arsenic (As) is a well-known human carcinogen and its dietary exposure has been found to be the major route of entry into general population. This study was performed to assess...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Induction of hypoxia-inducible factor-1alpha inhibits drug-induced apoptosis in the human leukemic cell line HL-60

Yook YJ, Seo YJ, Kang HJ, Ko SH, Shin HY, Lee JJ, Jeong G, Ahn HS

BACKGROUND: Leukemic cells originate from hypoxic bone marrow, which protects them from anti-cancer drugs. Although many factors that cause drug resistance in leukemic cells have been studied, the effect of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Gene Expression Profile Using cDNA microarray after treatment Arsenic Compound (As2O3, As4O6) in SiHa Cell

Seo YM, Park KE, Pang YG, Kim KC, Park SY, Ahn WS, Lee JM, Namkoong S, Kim DG

  • KMID: 2076651
  • Korean J Obstet Gynecol.
  • 2002 Jul;45(7):1191-1203.
OBJECTIVE: To obtain information on the growth inhibition effect of arsenic compounds and gene expression profiles using cDNA microarray technique in SiHa cell lines. METHODS: We cultured 103 SiHa cell...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Arsenic trioxide induces depolymerization of microtubules in an acute promyelocytic leukemia cell line

Baek JH, Moon CH, Cha SJ, Lee HS, Noh EK, Kim H, Won JH, Min YJ

BACKGROUND: Arsenic trioxide (As2O3) is a well-known and effective treatment that can result in clinical remission for patients diagnosed with acute promyelocytic leukemia (APL). The biologic efficacy of As2O3 in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Arsenic trioxide-induced apoptosis is independent of stress-responsive signaling pathways but sensitive to inhibition of inducible nitric oxide synthase in HepG2 cells

Kang SH, Song JH, Kang HK, Kang JH, Kim SJ, Kang HW, Lee YK, Park DB

  • KMID: 1097255
  • Exp Mol Med.
  • 2003 Apr;35(2):83-90.
Arsenic trioxide (As2O3) has been found to be remarkably effective in the treatment of patients with acute promyelocytic leukemia (APL). Although evidences for the proapoptotic activity of As2O3 have been...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Src Family Kinase Inhibitor PP2 Has Different Effects on All-Trans-Retinoic Acid or Arsenic Trioxide-Induced Differentiation of an Acute Promyelocytic Leukemia Cell Line

Yoon SG, Cheong HJ, Kim SJ, Kim KH, Lee SC, Lee N, Park HS, Won JH

  • KMID: 2167618
  • Cancer Res Treat.
  • 2013 Jun;45(2):126-133.
PURPOSE: Leukemic promyelocytes have the unique ability to undergo differentiation after exposure to retinoic acid and both differentiation and apoptosis after exposure to arsenic trioxide (ATO). Recent studies have shown...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of As2O3 and As4O6 in the Detection of SiHa Cervical Cancer Cell Growth Inhibition Pathway

Kim YW, Bae SM, Lee KH, Lee JM, Namkoong S, Lee IP, Kim CK, Seo JS, Sin JI, Kim YW, Ahn WS

  • KMID: 2166140
  • Cancer Res Treat.
  • 2004 Aug;36(4):255-262.
PURPOSE: An arsenical compound, As2O3, has been reported to be effective for treating acute leukemia and inducing apoptosis in many different tumor cells. In this study, the ability of As4O6...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr